跳至主要内容
临床试验/CTRI/2025/07/090905
CTRI/2025/07/090905尚未招募3 期

Clinical Study Of Shirish Agad In The Management Of Dadru

Dixit Thakur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年7月26日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Elimination of symptoms

研究概览

简要总结

Shirish Agad which is having both Vishagna as well as Kushtaghna property plays a very important role in reducing almost all the symptoms of Dadru like Kandu, Utsanmandala, Raag, Pidika And Twak rookshata.

Sirish Agad was effective in Kandu, Pidiks etc. but in some cases Twak rookshata got slightly increased during treatment: it may be because of the ruksha property of the drug. It has been found to be of acute origin and was able to get good results, so it can be considered as Sadhya Vyadhi only and but proper hygene and food habits should be maintained. Topical applications are found to be producing significant improvement in the disease management, so even if it is used alone without any internal medications can produce favorable results.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Sign And Symptoms: Kandu Pidika Raga Rukshta Utsanmandala.

排除标准

  • Patient under long standing medication.
  • Pregnant Women.
  • Lactating Women.
  • Chronicity more than 5 Years.
  • Pre Existing Skin Condition.

结局指标

主要结局

Elimination of symptoms

时间窗: 1 week

次要结局

未报告次要终点

研究者

发起方
Dixit Thakur
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dixit Thakur

Uttranchal Ayurvedic College and Hospital

研究点 (1)

Loading locations...

相似试验